3,4-dihydroxybenzohydroxamic acid has been researched along with Breast Neoplasms in 3 studies
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fourteen patients with advanced breast cancer were treated with the ribonucleotide reductase inhibitor didox 6 g m-2 given by intravenous infusion over 36 h every 3 weeks." | 2.67 | Phase II trial of didox in advanced breast cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. ( Brampton, MH; Harris, AL; Kaye, SB; Rubens, RD; Soukop, M; Williams, CJ, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Latif, GA | 1 |
| Al-Abd, AM | 1 |
| Tadros, MG | 1 |
| Al-Abbasi, FA | 1 |
| Khalifa, AE | 1 |
| Abdel-Naim, AB | 1 |
| Shah, KN | 1 |
| Wilson, EA | 1 |
| Malla, R | 1 |
| Elford, HL | 1 |
| Faridi, JS | 1 |
| Rubens, RD | 1 |
| Kaye, SB | 1 |
| Soukop, M | 1 |
| Williams, CJ | 1 |
| Brampton, MH | 1 |
| Harris, AL | 1 |
1 trial available for 3,4-dihydroxybenzohydroxamic acid and Breast Neoplasms
| Article | Year |
|---|---|
Phase II trial of didox in advanced breast cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Drug Evaluation; Humans; Hydroxamic Acids; Ribonu | 1991 |
2 other studies available for 3,4-dihydroxybenzohydroxamic acid and Breast Neoplasms
| Article | Year |
|---|---|
The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Su | 2015 |
Targeting Ribonucleotide Reductase M2 and NF-κB Activation with Didox to Circumvent Tamoxifen Resistance in Breast Cancer.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Movement | 2015 |